SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-23-085307
Filing Date
2023-11-09
Accepted
2023-11-09 17:09:12
Documents
15
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K f10k2022a1_cambellint.htm   iXBRL 10-K/A 38066
2 CERTIFICATION f10k2022a1ex31-1_cambell.htm EX-31.1 3607
3 CERTIFICATION f10k2022a1ex32-1_cambell.htm EX-32.1 4018
  Complete submission text file 0001213900-23-085307.txt   276234

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bimt-20220630.xsd EX-101.SCH 3246
5 XBRL DEFINITION FILE bimt-20220630_def.xml EX-101.DEF 17329
6 XBRL LABEL FILE bimt-20220630_lab.xml EX-101.LAB 35793
7 XBRL PRESENTATION FILE bimt-20220630_pre.xml EX-101.PRE 18429
9 EXTRACTED XBRL INSTANCE DOCUMENT f10k2022a1_cambellint_htm.xml XML 6552
Mailing Address UNIT NO. 5784 152 CHARTERED SQUARE BUILDING, 212/19 BANGKOK W1 10500
Business Address UNIT NO. 5784 152 CHARTERED SQUARE BUILDING, 212/19 BANGKOK W1 10500 7026050123
CAMBELL INTERNATIONAL HOLDING CORP. (Filer) CIK: 0001678848 (see all company filings)

IRS No.: 981310024 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 333-214469 | Film No.: 231393684
SIC: 2833 Medicinal Chemicals & Botanical Products